Market Research Report

A quick peek into the report

1.1   Product Definition
1.1.1   Inclusion and Exclusion Criteria
1.2   Market Scope
1.2.1   Scope of the Study
1.2.2   Key Questions Answered in the Report
1.3   Research Methodology
1.3.1   Nucleic Acid Sample Preparation Market: Research Methodology
1.3.2   Data Sources
1.3.2.1   Primary Data Sources
1.3.2.2   Secondary Data Sources
1.3.3   Market Estimation Model
1.3.4   Criteria for Company Profiling
1.4   Market Overview
1.4.1   Market Definition
1.4.2   Market Footprint and Growth Potential, $Million, 2021-2032
1.5   Addressable Market Size and Growth Potential ($Million), 2021-2032
1.5.1   Europe
1.6   Industry Participants Landscape

2.1   Industry Insights
2.1.1   Legal Requirements and Framework in Europe
2.2   Patent Analysis
2.2.1   Patent Filing Trend
2.2.2   Patent Analysis (by Year)
2.2.3   Patent Analysis (by Country)
2.2.4   Patent Analysis (by Region)
2.3   Impact of COVID-19 on the Nucleic Acid Sample Preparation Market

3.1   Overview
3.2   Market Drivers
3.2.1   Increasing Use of Nucleic Acid Molecules in Various Therapeutic Areas
3.2.2   Advancement in the Nucleic Acid Extraction/Isolation Techniques
3.2.3   Advantages of Automated Sample Preparation Workstations
3.2.4   Increasing Demand for Downstream Applications such as Next-Generation Sequencing (NGS)
3.3   Market Restraints
3.3.1   High Cost of Automated Workstations
3.3.2   Rigid Regulatory Standards
3.4   Market Opportunities
3.4.1   Technological Advancements in Automated Sample Preparation Workstations
3.4.2   Nucleic Acid Molecules for Biobanking in Healthcare
3.4.3   Growth in Emerging Nations

4.1   Overview
4.2   Corporate Strategies
4.2.1   Mergers and Acquisitions
4.2.2   Synergistic Activities
4.2.3   Business Expansions
4.3   Business Strategies
4.3.1   Product Launches
4.4   Market Share Analysis

5.1   Overview
5.2   Europe
5.2.1   Germany
5.2.2   France
5.2.3   U.K.
5.2.4   Italy
5.2.5   Spain
5.2.6   Rest-of-Europe

6.1   Overview
6.2   Endress+Hauser Group Services AG (Analytik Jena GmbH)
6.2.1   Company Overview
6.2.2   Role of Endress+Hauser Group Services AG (Analytik Jena GmbH) in the Global Nucleic Acid Sample Preparation Market
6.2.3   Key Customers of the Company
6.2.4   Key Competitors of the Company
6.2.5   Business Strategies
6.2.6   Financials
6.2.7   Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Region), $Million, 2019-2021
6.2.8   Key Insights about the Financial Health of the Company
6.2.9   Analyst Perspective
6.3   Eppendorf SE
6.3.1   Company Overview
6.3.2   Role of Eppendorf SE in the Nucleic Acid Sample Preparation Market
6.3.3   Key Competitors of the Company
6.3.4   Financials
6.3.5   Key Insights about the Financial Health of the Company
6.3.6   Analyst Perspective
6.4   F. Hoffmann-La Roche Ltd
6.4.1   Company Overview
6.4.2   Role of F. Hoffmann-La Roche Ltd in the Nucleic Acid Sample Preparation Market
6.4.3   Key Competitors of the Company
6.4.4   Business Strategies
6.4.5   Financials
6.4.6   Key Insights about the Financial Health of the Company
6.4.7   Analyst Perspective
6.5   Merck KGaA
6.5.1   Company Overview
6.5.2   Role of Merck KGaA in the Nucleic Acid Sample Preparation Market
6.5.3   Key Competitors of the Company
6.5.4   Financials
6.5.5   Key Insights about the Financial Health of the Company
6.5.6   Analyst Perspective
6.6   QIAGEN
6.6.1   Company Overview
6.6.2   Role of QIAGEN in the Nucleic Acid Sample Preparation Market
6.6.3   Key Customers of the Company
6.6.4   Key Competitors of the Company
6.6.5   Business Strategies
6.6.6   Financials
6.6.7   Key Insights about the Financial Health of the Company
6.6.8   Analyst Perspective
6.7   Tecan Trading AG
6.7.1   Company Overview
6.7.2   Role of Tecan Trading AG in the Nucleic Acid Sample Preparation Market
6.7.3   Key Customers of the Company
6.7.4   Key Competitors of the Company
6.7.5   Financials
6.7.6   Key Insights about the Financial Health of the Company
6.7.7   Analyst Perspective

Table 1:   Impact Analysis of Market Drivers, Restraints, and Opportunities on the Nucleic Acid Sample Preparation Market
Table 2:   Industry Participants' Landscape in the Global Nucleic Acid Sample Preparation Market
Table 3:   Cost of Automated Workstations

Figure 1:   Nucleic Acid Sample Preparation Market, $Million, 2021 and 2032
Figure 2:   Nucleic Acid Sample Preparation Market Segmentation
Figure 3:   Share of Nucleic Acid Sample Preparation Market (by Product), $Million, 2021-2032
Figure 4:   Share of Nucleic Acid Sample Preparation Market (by Workflow), $Million, 2021-2032
Figure 5:   Share of Nucleic Acid Sample Preparation Market (by Technology), $Million, 2021-2032
Figure 6:   Share of Nucleic Acid Sample Preparation Market (by Therapeutic Area), $Million, 2021-2032
Figure 7:   Share of Nucleic Acid Sample Preparation Market (by Application), $Million, 2021 and 2032
Figure 8:   Share of Nucleic Acid Sample Preparation Market (by End User), $Million, 2021 and 2032
Figure 9:   Nucleic Acid Sample Preparation Market (by Region)
Figure 10:   Nucleic Acid Sample Preparation Market Segmentation
Figure 11:   Nucleic Acid Sample Preparation Market: Research Methodology
Figure 12:   Primary Research Methodology
Figure 13:   Bottom-Up Approach (Segment-Wise Analysis)
Figure 14:   Top-Down Approach (Segment-Wise Analysis)
Figure 15:   Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 16:   Europe Nucleic Acid Sample Preparation Addressable Market, 2021-2032
Figure 17:   Nucleic Acid Sample Preparation Market, Patent Analysis (by Year), January 2019-December 2022
Figure 18:   Nucleic Acid Sample Preparation Market, Patent Analysis (by Country), January 2019-December 2022
Figure 19:   Nucleic Acid Sample Preparation Market, Patent Analysis (by Region), January 2019-December 2022
Figure 20:   Virus Testing Workflow
Figure 21:   NGS Applications in Laboratories during COVID-19
Figure 22:   Nucleic Acid Sample Preparation Market - Market Dynamics
Figure 23:   Techniques for Nucleic Acid Extraction/Isolation
Figure 24:   Benefits of Automated Nucleic Acid Sample Preparation
Figure 25:   Share of Key Developments, January 2019-November 2022
Figure 26:   Share of Synergistic Activities (by Company), January 2019-November 2022
Figure 27:   Number of Business Expansion Activities (by Company), January 2019-November 2022
Figure 28:   Number of Product Launches (by Company), January 2019-November 2022
Figure 29:   Market Share Analysis of the Global Nucleic Acid Sample Preparation Market (by Company), 2021
Figure 30:   Nucleic Acid Sample Preparation Market (by Region)
Figure 31:   Nucleic Acid Sample Preparation Market (by Region), $Million, 2021-2032
Figure 32:   Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 33:   Europe Nucleic Acid Sample Preparation Market (by Country), 2021 and 2032
Figure 34:   Germany Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 35:   France Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 36:   U.K. Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 37:   Italy Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 38:   Spain Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 39:   Rest-of-Europe Nucleic Acid Sample Preparation Market, $Million, 2021-2032
Figure 40:   Total Number of Companies Profiled
Figure 41:   Endress+Hauser Group Services AG (Analytik Jena GmbH): Product Portfolio
Figure 42:   Endress+Hauser Group Services AG (Analytik Jena GmbH): Overall Financials, $Million, 2019-2021
Figure 43:   Endress+Hauser Group Services AG (Analytik Jena GmbH): Revenue (by Segment), $Million, 2019-2021
Figure 44:   Endress+Hauser Group Services AG (Analytik Jena GmbH): R&D Expenditure, $Million, 2019-2021
Figure 45:   Eppendorf SE: Product Portfolio
Figure 46:   Eppendorf SE: Overall Financials, $Million, 2019-2021
Figure 47:   Eppendorf SE: Revenue (by Segment), $Million, 2019-2021
Figure 48:   Eppendorf SE: Revenue (by Region), $Million, 2019-2021
Figure 49:   Eppendorf SE: R&D Expenditure, $Million, 2019-2021
Figure 50:   F. Hoffmann-La Roche Ltd: Product Portfolio
Figure 51:   F. Hoffmann-La Roche Ltd: Overall Financials, $Million, 2019-2021
Figure 52:   F. Hoffmann-La Roche Ltd: Revenue (by Segment), $Million, 2019-2021
Figure 53:   F. Hoffmann-La Roche Ltd: Revenue (by Region), $Million, 2019-2021
Figure 54:   F. Hoffmann-La Roche Ltd: R&D Expenditure, $Million, 2019-2021
Figure 55:   Merck KGaA: Product Portfolio
Figure 56:   Merck KGaA: Overall Financials, $Million, 2019-2021
Figure 57:   Merck KGaA: Revenue (by Segment), $Million, 2019-2021
Figure 58:   Merck KGaA: Revenue (by Region), $Million, 2019-2021
Figure 59:   Merck KGaA: R&D Expenditure, $Million, 2019-2021
Figure 60:   QIAGEN: Product Portfolio
Figure 61:   QIAGEN: Overall Financials, 2019-2021
Figure 62:   QIAGEN: Revenue (by Segment), 2019-2021
Figure 63:   QIAGEN: Revenue (by Region), 2019-2021
Figure 64:   QIAGEN: R&D Expenditure, 2019-2021
Figure 65:   Tecan Trading AG: Product Portfolio
Figure 66:   Tecan Trading AG: Overall Financials, 2019-2021
Figure 67:   Tecan Trading AG: Revenue (by Segment), 2019-2021
Figure 68:   Tecan Trading AG: Revenue (by Region), 2019-2021
Figure 69:   Tecan Trading AG: R&D Expenditure, 2019-2021

Europe Nucleic Acid Sample Preparation Market Report Coverage

Europe Nucleic Acid Sample Preparation Market
Base Year	2021	Market Size in 2022	$1,307.4 Million
Forecast Period	2022-2032	Value Projection and Estimation by 2032	$3,356.7 Million
CAGR During Forecast Period	9.89%

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, product portfolio, and market penetration.

Some of the prominent names established in this market are:

•     Endress+Hauser Group Services AG
•     Eppendorf SE
•     F. Hoffmann-La Roche Ltd
•     Merck KGaA
•     QIAGEN
•     Tecan Trading AG

How can this report add value to an organization?

Growth/Marketing Strategy: Nucleic acid sample preparation is being used for genomics, proteomics, and other applications. Various companies are providing consumables and systems aid in the diagnosis of various therapeutic areas, which is also the key strategy for market players to excel in the current Europe nucleic acid sample preparation market.

Competitive Strategy: Key players in the Europe nucleic acid sample preparation market have been analyzed and profiled in the study, including manufacturers involved in new product launches, acquisitions, expansions, and strategic collaborations. Moreover, a detailed competitive benchmarking of the players operating in the Europe nucleic acid sample preparation market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Introduction to Europe Nucleic Acid Sample Preparation Market

The Europe nucleic acid sample preparation market is projected to reach $3,356.7 million by 2032 from $1,307.4 million in 2022, growing at a CAGR of 9.89% during the forecast period 2022-2032. The increased use of nucleic acid molecules in a variety of medicinal contexts is expected to fuel the growth of the nucleic acid sample preparation market in Europe. Furthermore, the region's nucleic acid sample preparation market is expanding due in large part to the increased demand for downstream applications such as next-generation sequencing (NGS) and other associated developments in nucleic acid extraction/isolation techniques.

Market Introduction

The nucleic acid sample preparation market in Europe is currently advancing to meet the increasing demand for prompt diagnostic information and targeted patient treatment. Various molecular procedures, including automated nucleic acid sample preparation workstations, have been developed to address this need. Furthermore, sample preparation plays a crucial role in precision medicine, ensuring the secure and effective application of personalized therapies. The market provides a diverse range of universal products with varying maximum throughputs, innovations, time durations, and other attributes, prompting companies to explore inventive ways to differentiate themselves. Notably, manufacturers have recently introduced application-specific nucleic acid purification devices and liquid handlers to cater to specific needs in the European market.

Impact

One of the main reasons for the anticipated expansion of the nucleic acid sample preparation market in the upcoming years is the rise in the use of nucleic acid molecules in several therapeutic areas. Sample preparation is typically an important phase in the accurate analysis of nucleic acids. Nuclease protection is one of the most important aspects to consider while processing nucleic acid samples. Nucleic acid extraction and isolation is the first stage in the area of molecular biology research, followed by recombinant procedures.

Market Segmentation:

Segmentation 1: by Country
• Germany
• France
• Italy
• Spain
• U.K.
• Rest-of-Europe

In 2021, Europe accounted for a share of 31.14% of the nucleic acid sample preparation market. The presence of some of the prominent companies in the market is a key factor driving the growth of the Europe region.

Recent Developments in the Europe Nucleic Acid Sample Preparation Market

• In November 2022, RevoluGen, a U.K.-based genomics company, announced that it had entered into an agreement with Tecan Trading AG, a pioneer and industry leader in laboratory automated processes, for the production and supply of Tecan's 96-well filter plates for use in RevoluGen's automated Fire Monkey High Molecular Weight (HMW)-DNA extraction kits.